AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Lyell Immunopharma, Inc.

$11.04 -$17.94 (-61.90%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$11.30
Day Range
$10.79$11.39
Year Range
$7.20$45.00
Market Cap
270.54M
AVG Volume
173.68K
Trailing/Forward PE
-0.69/-
PEG ratio
0.02
Dividend Yield
-
Next Earnings Date
2026-11-10
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
020K40K60K80K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LYEL Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q227K
26 Q131K
25 Q436K
25 Q341K
25 Q260K
25 Q165K
24 Q461K
24 Q363K
24 Q254K
24 Q168K
Net Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LYEL Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-248.48M
26 Q1-246.41M
25 Q4-274.45M
25 Q3-325.66M
25 Q2-331.4M
25 Q1-334.52M
24 Q4-342.99M
24 Q3-203.99M
24 Q2-210.26M
24 Q1-228.34M
Operating Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LYEL Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-192.06M
26 Q1-191.86M
25 Q4-203.07M
25 Q3-342.91M
25 Q2-356.16M
25 Q1-360.55M
24 Q4-358.75M
24 Q3-217.44M
24 Q2-227.51M
24 Q1-241.85M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: LYEL

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 10 Nov 2026.

Lyell Immunopharma, Inc.
LYEL
Stockpicker

Video analysis: LYEL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LYEL

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.